First Trust Advisors LP Gritstone Bio, Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$2.63 - $8.09 $102,188 - $314,336	-38,855 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$5.69 - $8.17 $23,653 - $33,962	4,157 Added 11.98%	38,855 $258,000
Q1 2020 May 06, 2020	SELL	$5.47 - $11.3 $36,807 - $76,037	-6,729 Reduced 16.24%	34,698 $202,000
Q4 2019 Feb 03, 2020	SELL	$7.07 - $11.61 $5,472 - $8,986	-774 Reduced 1.83%	41,427 $372,000
Q3 2019 Nov 04, 2019	BUY	$8.45 - $12.28 $356,598 - $518,228	42,201 New	42,201 $364,000

1.2M

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.